Newsletter #330 03/02/08
THE MOSS REPORTS - CANCER DECISIONS NEWSLETTER
A BAD DECISION ON AVASTIN
On Friday, Feb. 22, 2008, top administrators of the Food and Drug
Administration (FDA) approved the drug Avastin for the treatment of
advanced breast cancer. Avastin, which has already been approved for
colon and lung cancer, is controversial because it has never been shown
to extend overall survival (OS) in breast cancer patients.
To read or listen to this week's newsletter, please go to:
http://www.cancerdecisions.com/030208.html
[and scroll down page]
Yahoo! Groups Links
<*> To visit your group on the web, go to:
http://groups.yahoo.com/group/cancercured/
<*> Your email settings:
Individual Email | Traditional
<*> To change settings online go to:
http://groups.yahoo.com/group/cancercured/join
(Yahoo! ID required)
<*> To change settings via email:
mailto:cancercured-digest@yahoogroups.com
mailto:cancercured-fullfeatured@yahoogroups.com
<*> To unsubscribe from this group, send an email to:
cancercured-unsubscribe@yahoogroups.com
<*> Your use of Yahoo! Groups is subject to:
Tidak ada komentar:
Posting Komentar